T cell clones were established from peripheral blood of a patient with severe aplastic anemia. 8 of 18 individual clonal T cell populations stably coexpressed CD4 and CD8 molecules, a phenotype characteristic for thymocytes and a minor subpopulation of circulating T lymphocytes. Analysis of T cell receptor genes revealed identical rearrangements of T cell receptor beta chain genes, suggesting clonality of these T cells. CD4+/CD8+ T cells clones were found to be efficiently cytotoxic towards autologous lymphoblasts. Autocytotoxicity could be blocked by a CD3 MAb, a MAb specific for monomorphic MHC class II determinants, and particularly, by an MHC-DP-specific MAb, suggesting specificity for autologous DP molecules. Perhaps more important, CD4+/CD8+ T cell clones inhibited differentiation of autologous progenitor enriched bone marrow cells in vitro by a direct cell-mediated mechanism. These data suggest that circulating cytotoxic CD4+/CD8+ T cell clones specific for autologous MHC-DP determinants may be involved in hematopoietic failure in some cases of aplastic anemia.
Introduction
Normal T lymphocyte differentiation results in two major subpopulations, CD4+/CD8-helper/inducer and CD4-/CD8' cytotoxic/suppressor T lymphocytes (1) . These T cells express an a/:3 T cell receptor (TCR)' and recognize antigen in association with MHC-class I molecules (CD4-/CD8' T cells) and class II molecules (CD4+/CD8-T cells), respectively (2, 3) . During T lymphocyte differentiation, CD4 and CD8 molecules are coexpressed on immature cortical thymocytes. It has been proposed that these CD4+/CD8+ thymocytes either give rise to mature CD4+/CD8-and CD4-/CD8+ thymocytes or are eliminated during differentiation in the course of a process that leads to acquisition ofselftolerance (4) (5) (6) (7) . Besides mature CD4+/CD8-and CD4-/CD8+ T cells, a minor T cell subpopulation of 1-5% 1. Abbreviations used in this paper: BFU-E, burst-forming unit-erythrocyte; B-LCL, B-lymphoblastoid cell line; CFU-GM, colony-forming unit-granulocyte/macrophage; TCR, T cell receptor; TNF, tumor necrosis factor.
of peripheral blood T lymphocytes has been identified expressing neither CD4 nor CD8 molecules (8) (9) (10) . These CD4-/CD8-T cells of not well defined function express primarily a TCR-y/b in association with CD3. On the other hand, mature T lymphocytes coexpressing CD4 and CD8 molecules were found in low frequencies (0.5-8% of circulating T lymphocytes) in peripheral blood (1 1).
Acquired severe aplastic anemia consists of a group of diseases that are characterized by reduced bone marrow activity leading to a decrease in circulating cells of various hematopoietic lineages. The mechanisms involved in aplastic anemia are thought to include stem cell damage, abnormalities of the hematopoietic microenvironment, as well as inhibition of hematopoiesis by the immune system. There is growing support for the view that aplastic anemia can be mediated by impaired T cell function (12) (13) (14) (15) (16) . Regulatory effects of mediators released by T lymphocytes, especially IFN--y and tumor necrosis factor alpha (TNF-a), have been discussed in this context (17) (18) (19) . In other reports, T cell-mediated inhibition ofbone marrow activity was demonstrated to be MHC restricted, suggesting the involvement of specific cell/cell interactions in bone marrow suppression (20, 21) .
Here we describe T cell clones that were established from peripheral blood of a patient with acquired severe aplastic anemia. A large proportion of these T cell clones showed stable coexpression of CD4 and CD8 molecules. We functionally characterized these T cell clones and investigated their ability to influence bone marrow differentiation in vitro. Cell cultures. PBL obtained after density centrifugation with Ficoll Hypaque (Pharmacia, Munich, FRG) were stimulated at 5 X I05 cells/ ml with equal cell numbers of the lymphoblastoid B cell line Laz5O9 (irradiated, 60 Gray) in 24-well culture plates (Costar, Cambridge, MA). Culture medium was RPMI 1640 (Gibco Laboratories, Paisley, Scotland) supplemented with 2 mM L-glutamine (Gibco Laboratories), 100 U/ml penicillin (Gibco Laboratories), 0.1 mg/ml streptomycin (Gibco Laboratories), 10% heat-inactivated human serum, and pretested concentrations ofIL-2-containing, T cell-conditioned medium.
Methods
Cells were cultivated at 37°C, 7% C02, humidified atmosphere for 7 d and restimulated by adding 5 X 105 irradiated Laz5O9 stimulator cells with 0.3 T cells/well in 96-well V-bottomed culture plates (Costar) using Laz 509 and allogeneic PBL (each 5 X 104/well, irradiated) as feeder cells (see also Fig. 3, lane 4) . Growing T cell clones were propagated in IL-2-containing culture medium and restimulated with feeder cells about every 10 d.
Transformation with EBV. Transformation of resting B cells was performed after preparation of PBL and removal of T lymphocytes by rosetting with sheep red blood cells (22) . We used I07 cells with EBVcontaining supernatant from the marmoset cell line B95/8.
Immunofluorescence analysis. Indirect immunofluorescence analysis of T cells was performed at 40C as described (2) . MAbs (23) specific for CD1 (19ThyIA8), CD2 (3PT2H9), CD3 (RW28C8), CD4 (12T4D Il), CD5 (24T6G12), CD6 (3PT12B8), CD8 (21Thy2D3), IL-2 receptor (IHT4) and MHC class II (6) (27) at 42°C using 50% formamid (28) . Membranes were washed at 68°C and exposed to Kodak XAR films.
Results
Expansion of CD4+/CD8+ peripheral blood T lymphocytes. We reanalyzed the proportion of CD4+/CD8+ T lymphocytes during in vitro expansion in bulk culture of W.M. cells at different time points in the initial cell expansion. Thus, when T lymphocytes of the patient at day 7 of in vitro culture were analyzed by two-color immunofluorescence, 10% of CD4+/CD8+ T cells were detected. After further in vitro expansion, the amount of CD4+/CD8+ T cells increased up to 25% within the next 4 wk. In marked contrast to lymphocytes obtained and activated at the time of symptomatic disease, no increase in the number ofCD4+/CD8+ cells was observed when T lymphocytes obtained during remission were stimulated and expanded in vitro (not shown).
Analysis of TCR gene rearrangements by Southern blot hybridization. TCR fl chain gene rearrangements were analyzed to investigate whether CD4/CD8-coexpressing T cell clones established from the patient with aplastic anemia represented distinct clonal populations or whether these clones possibly descended from a single T cell. As shown in Fig. 3 A, when five CD4+/CD8+ T cell clones were analyzed by Southern blotting, they showed a germline configuration after cleavage of DNA with Hind III and hybridization with a TCR f chain constant region probe (lanes 1-4, and 7) . Using Eco RI, we found in all five clones two identically rearranged bands of 13.0 and 8.0 kb, in addition to a 4.0-kb germline fragment (Fig. 4 B, lanes 1-4 Cytotoxic activity ofCD4+/CD8' T cell clones. To characterize the cytotoxic activity of CD4+/CD8' T cell clones we used a panel of 5tCr-labeled B-LCLs as target cells in standard cytotoxicity assays. As shown for T cell clone WM2 in Fig. 4 Fig. 4 B, autologous target cells were also killed by WM2 with an intermediate efficiency. In contrast, WM4, which is representative for two CD4-/CD8+ T cell clones derived from the same patient (shown in Fig. 4 C) 75 and 93% inhibition of colony formation, respectively. This inhibition was dependent on the physical presence of T cell clone WM2 in bone marrow culture. Thus, when cell-free supernatants of WM2 were added in concentrations of 10 and 20% (vol/vol) to progenitor cells, no inhibitory effects were observed. The influence of the CD4+/CD8+ T cell clone WM2 was specific for autologous bone marrow differentiation, since colony formation of progenitor cells from an allogeneic donor was not inhibited by WM2 (Table I) . Production ofIFN-y and TNF-a by Tcell clone WM2. IFNy has been reported to represent a potent inhibitor of myelopoietic colony growth (30, 31) . In this regard we have previously described a T cell line (SMAA), established from a different aplastic patient, that inhibited progenitor cell maturation by releasing high concentrations ofIFN-y (17) . To investigate further the mechanism of bone marrow suppression mediated by T cell clone WM2, we determined the amount of IFN-y and TNF-a released by WM2, compared with various T cell clones and cell lines, including the cell line SMAA. CD4+/CD8+ T cells were only observed neonatally in the developing immune system (32) . Unexpectedly, several CD4+/CD8+/CD3' T cell clones were obtained from one patient with severe aplastic anemia after alloactivation of his peripheral blood T lymphocytes and their further expansion in vitro. It is possible that such cells had a growth advantage during in vitro expansion, and were, therefore, obtained at high frequency despite their normal abundance in peripheral blood. This view is supported by the observation that repeated in vitro culture of uncloned alloactivated peripheral blood T cells from the patient resulted in an increase in the proportion of CD4+/CD8+ T cells (up to 25%). More- Transient coexpression ofCD4 and CD8 can be induced by stimulating normal CD4+/CD8-peripheral blood T lymphocytes with high doses of mitogen and T cell-derived supernatants (33) . Moreover, CD4+/CD8+ T cell clones were obtained earlier using in vitro conditions where T cell growth was strictly dependent on IL-4 (addition of rIL-4 and rIL-2 MAb) (34) . In the present experiments, however, the phenotype of WM2 was stable for several months of in vitro expansion and did not change whether the cells were grown in IL-2 or IL-4 or T cellconditioned medium (not shown). Moreover, the fact that parallel establishment of T cell cultures from this patient resulted on one hand (symptomatic disease) in 25% of CD4+/CD8+ T lymphocytes, but on the other hand (remission) did not yield double positive T cells, argues against an influence of culture conditions such as exogenous lymphokines or mitogens on coexpression of CD8 with CD4.
Functional properties of CD4+/CD8+ T cells are less well defined. As reported by others, CD4+/CD8+ T cell clones produce similar patterns of lymphokines, although in different quantities, when compared with T cell clones of other phenotypes (35) . They were also shown to exhibit helper cell function and MHC-unrestricted cytotoxicity. Further analysis of a CD4+/CD8+ T cell clone suggested that both CD4 and CD8 molecules were involved in signal transduction in the course of T cell activation (36, 37 (40, 41) , although autoreactive T cell clones specific for MHC-DP molecules have not been reported so far. Note that CD4-/CD8+ T cell clones from the same donor showed no cytolytic activity towards autologous targets (Table III) .
Earlier reports demonstrated that bone marrow activity is modulated by subpopulations of T lymphocytes exhibiting either enhancing or inhibitory effects on progenitor cell growth in vitro (12) (13) (14) (15) (16) (17) (18) (42) (43) (44) . In this regard, IFN-'y (30, 31) and 
